Reports of outbreaks of varicella in highly immunized groups have increased
concern about the effectiveness of varicella vaccine.
To assess whether the effectiveness of varicella vaccine is affected
either by time since vaccination or by age at the time of vaccination.
Case-control study conducted from March 1997 through June 2003.
Twenty different group practices in southern Connecticut.
Case subjects, identified by active surveillance of all practices, consisted
of 339 eligible children 13 months or older who were clinically diagnosed
as having chickenpox and who also had a polymerase chain reaction (PCR) test
result that was positive for varicella-zoster virus DNA. For each case subject,
2 controls were selected, matched by both age and pediatric practice.
Main Outcome Measures
The effectiveness of the vaccine, especially the effects of time since
vaccination and age at the time of vaccination, adjusted for possible confounders.
Although the adjusted overall effectiveness of the vaccine was 87% (95%
confidence interval, 81%-91%; P<.001), there was
a substantial difference in the vaccine's effectiveness in the first year
after vaccination (97%) and in years 2 to 8 after vaccination (84%, P = .003). The vaccine's effectiveness in year 1 was substantially
lower if the vaccine was administered at younger than 15 months (73%) than
if it was administered at 15 months or older (99%, P =
.01), although the difference in effectiveness overall for children immunized
at younger than 15 months was not statistically significantly different than
for those immunized at 15 months or older (81% vs 88%, P = .17). Most cases of chickenpox in vaccinees were mild.
Although varicella vaccine is effective, its effectiveness decreases
significantly after 1 year, although most cases of breakthrough disease are
mild. If administered at younger than 15 months, the vaccine's effectiveness
was lower in the first year after vaccination, but the difference in effectiveness
was not statistically significant for subsequent years.